VALENTI, MARIO
 Distribuzione geografica
Continente #
AS - Asia 161
NA - Nord America 99
EU - Europa 17
SA - Sud America 16
AF - Africa 1
Totale 294
Nazione #
US - Stati Uniti d'America 96
SG - Singapore 80
CN - Cina 44
VN - Vietnam 23
BR - Brasile 9
GB - Regno Unito 8
IT - Italia 5
HK - Hong Kong 3
AR - Argentina 2
EC - Ecuador 2
ID - Indonesia 2
MX - Messico 2
PY - Paraguay 2
QA - Qatar 2
UZ - Uzbekistan 2
HN - Honduras 1
IE - Irlanda 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
MY - Malesia 1
NL - Olanda 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
TN - Tunisia 1
VE - Venezuela 1
Totale 294
Città #
Singapore 39
San Jose 37
Beijing 9
Ashburn 7
Ho Chi Minh City 7
Pisa 5
Council Bluffs 4
Hanoi 4
New York 4
Santa Clara 4
Boardman 3
Hong Kong 3
Poplar 3
Atlanta 2
Doha 2
Mexico City 2
Porto Alegre 2
Salt Lake City 2
Tashkent 2
Amsterdam 1
Anápolis 1
Buffalo 1
Bến Tre 1
Campinas 1
Can Tho 1
Chicago 1
Ciudad del Este 1
Da Lat 1
Da Nang 1
Dallas 1
Denver 1
Dublin 1
Elk Grove Village 1
Fortaleza 1
Fresno 1
Fátima 1
Greenwood Village 1
Guayaquil 1
Holley 1
Hudson 1
Jacksonville 1
Kampong Loyang 1
Kuwait City 1
La Ceiba 1
Lanús 1
London 1
Los Angeles 1
Manchester 1
Manila 1
Maracaibo 1
Medan 1
Medina 1
Mendoza 1
Ninh Bình 1
Orem 1
Paranaíba 1
Petaling Jaya 1
Phoenix 1
Pouso Alegre 1
Quito 1
Quận Bình Thạnh 1
Rio de Janeiro 1
Saint Albans 1
San Lorenzo 1
Sfax 1
Tân An 1
Vinh 1
Warsaw 1
York 1
Totale 191
Nome #
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study – IL PSO (Italian landscape psoriasis) 50
Guselkumab Retention, Effectiveness, and Safety in Psoriasis: A 260-Week Real-World Multicenter Retrospective Study Exploring the Role of Concomitant PsA–IL PSO (Italian Landscape Psoriasis) 49
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 45
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis) 38
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 29
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 25
Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis) 25
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS) 23
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 19
Totale 303
Categoria #
all - tutte 622
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 622


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026301 0 0 0 16 72 35 38 27 28 58 23 4
2026/20272 2 0 0 0 0 0 0 0 0 0 0 0
Totale 303